The short version of regulatory status fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-07-02. Anything still debated is marked as such rather than presented as settled.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
After being incited to rid the country of the gachupines (a disparaging term for Peninsulares), Hidalgo's forces indiscriminately massacred hundreds of Criollos and Peninsulares who had taken refuge at the Alhóndiga de Granaditas in Guanajuato. In Venezuela during his Admirable Campaign, Simón Bolívar instituted a policy of a war to the death, in which royalist Spanish Americans would be purposely spared but even neutral Peninsulares would be killed, to drive a wedge between the two groups. This policy laid the ground for the violent royalist reaction under Boves. Often though, royalism or patriotism simply provided a banner to organize the aggrieved, and the political causes could be discarded just as quickly as they were picked up. The Venezuelan Llaneros switched to the Patriot banner once the elites and the urban centers became securely royalist after 1815, and it was the royal army in Mexico that ultimately brought about that nation's independence.
The middle layer of the heart wall is the myocardium, which is the cardiac muscle—a layer of involuntary striated muscle tissue surrounded by a framework of collagen. The cardiac muscle pattern is elegant and complex, as the muscle cells swirl and spiral around the chambers of the heart, with the outer muscles forming a figure 8 pattern around the atria and around the bases of the great vessels and the inner muscles, forming a figure 8 around the two ventricles and proceeding toward the apex. This complex swirling pattern allows the heart to pump blood more effectively. There are two types of cells in cardiac muscle: muscle cells which have the ability to contract easily, and pacemaker cells of the conducting system. The muscle cells make up the bulk (99%) of cells in the atria and ventricles. These contractile cells are connected by intercalated discs which allow a rapid response to impulses of action potential from the pacemaker cells. The intercalated discs allow the cells to act as a syncytium and enable the contractions that pump blood through the heart and into the major arteries. The pacemaker cells make up 1% of cells and form the conduction system of the heart. They are generally much smaller than the contractile cells and have few myofibrils which gives them limited contractibility. Their function is similar in many respects to neurons. Cardiac muscle tissue has autorhythmicity, the unique ability to initiate a cardiac action potential at a fixed rate—spreading the impulse rapidly from cell to cell to trigger the contraction of the entire heart.
The Gent hyperelastic material model is a phenomenological model of rubber elasticity that is based on the concept of limiting chain extensibility. In this model, the strain energy density function is designed such that it has a singularity when the first invariant of the left Cauchy-Green deformation tensor reaches a limiting value
The election saw the BN achieve a landslide victory, securing 148 out of 177 parliamentary seats and control of 11 state assemblies, further consolidating Mahathir's leadership. In 1987, Mahathir established the Langkawi Development Board and declared the island a duty-free zone. This was followed by the construction of key infrastructure, including the Kuah jetty and Langkawi International Airport in 1988, contributing to the island's transformation into a major tourist destination.
Sources: en.wikipedia.org
=== 2016–present: Departure from Valve === Laidlaw announced his departure from Valve in January 2016. He said the primary reason for his departure was his age, and that he planned to return to writing stories. He felt he was becoming a "negative force" at Valve and hampering the creative process, saying: "I think at some point you need to let the people who are the fans and the creators who've come in because of what they learned from you maybe, and let them have that. We didn't need me going, 'Well, the G-Man wouldn't do that in my day.'" Laidlaw also tired of the FPS genre and of solving storytelling problems in a Half-Life-style narrative. He said he had "always hoped that we'd stumble into a more expansive vocabulary or grammar for storytelling within the FPS medium, one that would let you do more than shoot or push buttons, or push crates". On August 25, 2017, Laidlaw published a short story, "Epistle 3", describing it as "a snapshot of a dream I had many years ago". Journalists interpreted it as a summary of what could have been the plot for Half-Life 2: Episode Three. Laidlaw denied this, saying "all the real story development can only happen in the crucible of developing the game". In 2023, Laidlaw said he regretted publishing the story. He said he had been "deranged" and "completely out of touch" at the time, and that it had created problems for his former colleagues at Valve. In 2020, Valve released the VR game Half-Life: Alyx.
=== Sublingual administration === Estradiol tablets can be taken sublingually instead of orally. Non-micronized estradiol tablets in doses of 0.125, 0.25, and 1 mg were previously marketed for use by sublingual administration under brand names such as Diogynets, Estradiol Membrettes, and Dimenformon in the 1950s. Non-micronized estradiol has poor water solubility, but micronized estradiol is rapidly absorbed by the sublingual route. All oral estradiol tablets are micronized, as this improves the efficiency of estradiol absorption in the gastrointestinal tract. Likewise, all oral estradiol valerate tablets seem to be micronized. The sublingual route is, in actuality, probably a combination of sublingual and oral delivery of estradiol due to incidental swallowing of some of the estradiol. The absorption of sublingual estradiol can be attributed to the rich vascularization under the tongue. With administration of an oral estradiol tablet sublingually, complete dissolution of the tablet occurs within a few minutes and circulating levels of estradiol begin to rise within 5 minutes. Maximal levels of estradiol occur after 30 to 60 minutes of administration. After this, estradiol levels drop steeply within 4 hours, and this is followed by a more gradual decline in levels of estradiol and a return to baseline concentrations by 24 hours. The rapid rise and steep fall of estradiol levels with sublingual administration of estradiol is analogous to the case of intravenous injection and intranasal administration of the hormone.
==== Enzymes ==== Industrial fermentation can be used for enzyme production, where proteins with catalytic activity are produced and secreted by microorganisms. The development of fermentation processes, microbial strain engineering and recombinant gene technologies has enabled the commercialization of a wide range of enzymes. Enzymes are used in all kinds of industrial segments, such as food (lactose removal, cheese flavor), beverage (juice treatment), baking (bread softness, dough conditioning), animal feed, detergents (protein, starch and lipid stain removal), textile, personal care and pulp and paper industries.
== History == Basilea Pharmaceutica was founded in 2000 as a corporate spin-off of the pharmaceutical company Roche. In 2002, Chinese subsidiary Basilea Pharmaceutica China Ltd. (BPC) was founded and was located in the Haimen Economic and Technological Development Zone in the city of Nantong in the Chinese province of Jiangsu, north of Shanghai. With the listing on the Swiss stock exchange in March 2004 at a price of CHF 98 per share, Basilea realised gross proceeds of more than CHF 200 million. In 2012, Basilea sold the worldwide rights to Toctino, a dermatology drug developed by Basilea that was approved and marketed in various European countries in 2008, to Stiefel Labs, a subsidiary of the British pharmaceutical company GlaxoSmithKline, for CHF 216 million. At the beginning of 2013, Basilea received orphan drug status in the USA for the antifungal drug Isavuconazole for the treatment of invasive fungal infections, which at the time, analysts estimated to be worth up to CHF 150 million per year. Isavuconazole was developed in phase III in conjunction with pharmaceutical company Astellas Pharma. In March 2015, Isavuconazole was approved in the US, followed by the entire EU in October of the same year. In the following years, the drug was also approved in Japan, several Eurasian countries, Australia and China.
Since at least 2013, scientists have been trying to develop synthetic third-generation vaccines by reconstructing the outside structure of a virus; it was hoped that this would help prevent vaccine resistance. Principles that govern the immune response can now be used in tailor-made vaccines against many noninfectious human diseases, such as cancers and autoimmune disorders. For example, the experimental vaccine CYT006-AngQb has been investigated as a possible treatment for high blood pressure. Factors that affect the trends of vaccine development include progress in translatory medicine, demographics, regulatory science, political, cultural, and social responses.
Sources: en.wikipedia.org
The Berlin Wall fell on 9 November 1989 during the Peaceful Revolution, marking the beginning of the destruction of the figurative Iron Curtain, as East Berlin transit restrictions were overwhelmed and discarded. Sections of the wall were breached, and planned deconstruction began the following June. It was one of the series of events that started the fall of communism in Central and Eastern Europe. The fall of the inner German border took place shortly afterward. An end to the Cold War was declared at the Malta Summit in early December, and German reunification took place in October the following year.
=== Structure === Fialuridine is a synthetic pyrimidine nucleoside analogue with the molecular formula C9H10FIN2O5 and a molecular weight of 372.09 g/mol. Structurally, it consists of a substituted pyrimidine base covalently linked to a modified pentose sugar. The base component is a 5-iodo-substituted pyrimidine-2,4-dione ring. The pyrimidine ring is aromatic, containing two carbonyl groups at positions 2 and 4. The uracil derivative also contains an iodine atom at position 5. The attached sugar is a five-membered furanose ring that differs from natural deoxyribose in two ways: it has a fluorine atom at the second carbon (2-deoxy-2-fluoro substitution) and adopts the arabino configuration (fluor pointing up, 3’hydroxyl pointing down). The sugar ring is saturated and non-aromatic. The modified base and sugar are connected via a β-N1 glycosidic bond between the anomeric carbon of the sugar and the N1 nitrogen of the pyrimidine ring. All these structural features correspond to similar pyrimidine analogues.
== Radioactive primordial nuclides == Although it is estimated that about 35 primordial nuclides are radioactive (see list of nuclides), it is very hard to determine the exact number of radioactive primordials, as there are many extremely long-lived nuclides whose half-lives are still unknown; in fact, all nuclides heavier than dysprosium-164 are theoretically radioactive. For example, it is predicted theoretically that all isotopes of tungsten, including those indicated by even the most modern empirical methods to be stable, must be radioactive to alpha decay, but this can be detected experimentally only for 180W. Similarly, all four primordial isotopes of lead are expected to decay to mercury, but the predicted half-lives are so long (some exceeding 10100 years) that such decays could hardly be observed in the near future. Nevertheless, the number of nuclides with half-lives so long that they cannot be measured with present instruments—and are considered from this viewpoint to be stable nuclides—is limited. Even when a "stable" nuclide is found to be radioactive, it merely moves from the stable to the unstable list of primordials, and the total number of primordial nuclides remains unchanged. For practical purposes, such nuclides, whose radioactivity is not detectable by ordinary means, may be considered stable for all purposes outside specialized research. These 35 primordial radionuclides are isotopes of 28 elements (cadmium, neodymium, osmium, samarium, tellurium, uranium, and xenon each have two primordial radioisotopes).
SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa. The foremost metabolic effect of this is to inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. They act by inhibiting sodium/glucose cotransporter 2 (SGLT2). SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. As of 2014, several medications of this class had been approved or were under development. In studies on canagliflozin, a member of this class, the medication was found to enhance blood sugar control as well as reduce body weight and systolic and diastolic blood pressure.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.